SCHEMBL3852545

SCHEMBL3852545

O=C(c1ccc(Cl)cc1)N1CCN(c2ncnc3ccc(-c4c[nH]nc4-c4ccc(F)cc4)cc23)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 4/20 0.48
SMO Q99835 2/20 0.46
HSP90AA1 P07900 1/20 0.45
KIT P10721 5/20 0.45
PDGFRB P09619 1/20 0.44
CYP2C19 P33261 5/20 0.44
CYP3A4 P08684 5/20 0.44
CYP1A2 P05177 4/20 0.44
CLK4 Q9HAZ1 4/20 0.44
LMNA P02545 3/20 0.44
ALDH1A1 P00352 3/20 0.44
HIF1A Q16665 3/20 0.44
CYP2D6 P10635 2/20 0.44
TSHR P16473 2/20 0.44
USP2 O75604 2/20 0.44
MAPK1 P28482 1/20 0.44
HSD17B10 Q99714 1/20 0.44
MAPK7 Q13164 1/20 0.44
CYP2C9 P11712 1/20 0.43
KDM4E B2RXH2 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849396 0.86 AKT1 (0.50) AKT1PDGFRBCYP2C19CYP3A4CYP1A2
SCHEMBL3856169 0.82 PDGFRB (0.43) AKT1KITPDGFRBCYP2C19CYP3A4
SCHEMBL3849265 0.82 CYP3A4 (0.56) CYP2C19CYP3A4CYP1A2CLK4LMNA
SCHEMBL3848419 0.81 CYP3A4 (0.63) CYP2C19CYP3A4CYP1A2CLK4LMNA
SCHEMBL3848700 0.80 CYP3A4 (0.48) PDGFRBCYP2C19CYP3A4CYP1A2CLK4
SCHEMBL3845114 0.80 CYP3A4 (0.52) PDGFRBCYP2C19CYP3A4CYP1A2CLK4
SCHEMBL3852755 0.80 AKT1 (0.70) AKT1SMOPDGFRBCYP3A4CYP1A2
SCHEMBL3849819 0.80 ACHE (0.50) PDGFRBCYP2C19CYP3A4CYP1A2CLK4
SCHEMBL3846990 0.78 ACHE (0.54) CYP2C19CYP3A4CYP1A2CLK4LMNA
SCHEMBL3849667 0.78 CYP3A4 (0.50) KITCYP2C19CYP3A4CYP1A2CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed